Anti-tumor activities of farnesyltransferase inhibitors

被引：0
|
作者：
Kohl, NE
Anthony, NJ
Conner, MW
deSolms, SJ
Gibbs, JB
Graham, L
Hartman, GD
Koblan, KS
Omer, CA
Pellicer, A
Williams, TM
Windle, JJ
Oliff, A
机构：
[1] Merck Res Labs, W Point, PA 19486 USA
[2] NYU, Med Ctr, Taipei 10016, Taiwan
[3] Canc Therapy & Res Ctr, San Antonio, TX 78229 USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
797
引用
收藏
页码：A993 / A993
页数：1
相关论文
共 50 条
  • [31] Progress in the evaluation of CDK inhibitors as anti-tumor agents
    McInnes, Campbell
    DRUG DISCOVERY TODAY, 2008, 13 (19-20) : 875 - 881
  • [32] Potentiation of anti-tumor immune effects by PARP Inhibitors
    Chabanon, R.
    Muirhead, G.
    Krastev, D.
    Adam, J.
    Garrido, M.
    Morel, D.
    Dorvault, N.
    Pettitt, S.
    Tutt, A. N. J.
    Marabelle, A.
    Soria, J. C.
    Lord, C. J.
    Postel-Vinay, S.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S132 - S132
  • [33] Immunomodulatory, Anti-Inflammatory and Anti-Tumor Activities of Nigella Sativa
    Majdalawieh, A. F.
    Hmaidan, R. I.
    Carr, R. I.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S194 - S195
  • [34] Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin
    Yue, G. G. L.
    Chan, B. C. L.
    Kwok, F. H. F.
    Ji, C. J.
    Fung, K. P.
    Leung, P. C.
    Tan, N. H.
    Lau, C. B. S.
    PLANTA MEDICA, 2012, 78 (11) : 1090 - 1090
  • [35] Anti-tumor and anti-carcinogenic activities of triterpenoid, β-boswellic acid
    Huang, MT
    Badmaev, V
    Ding, Y
    Liu, Y
    Xie, JG
    Ho, CT
    BIOFACTORS, 2000, 13 (1-4) : 225 - 230
  • [36] STUDIES ON THE ANTI-TUMOR ACTIVITIES OF PYRIMIDINONE-INTERFERON INDUCERS .2. POTENTIATION OF ANTI-TUMOR RESISTANCE MECHANISMS
    MILAS, L
    HUNTER, N
    ITO, H
    LOTZOVA, E
    STRINGFELLOW, DA
    CLINICAL & EXPERIMENTAL METASTASIS, 1983, 1 (03) : 213 - 222
  • [37] Farnesyltransferase inhibitors and anti-Ras therapy
    Gibbs, JB
    Kohl, NE
    Koblan, KS
    Omer, CA
    SeppLorenzino, L
    Rosen, N
    Anthony, NJ
    Conner, MW
    deSolms, SJ
    Williams, TM
    Graham, SL
    Hartman, GD
    Oliff, A
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 38 (01) : 75 - 83
  • [38] Immune-based Anti-tumor Effects of BRAF Inhibitors/MEK Inhibitors
    Kuske, M.
    Praetorius, C.
    Westphal, D.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 41 - 41
  • [39] Farnesyltransferase inhibitor has anti-inflammatory and anti-tumor effects of HCC cell lines on NASH like condition
    Yamada, Kohei
    Tanaka, Tomokazu
    Matsufuji, Shohei
    Ito, Kotaro
    Kitajima, Yoshihiko
    Noshiro, Hirokazu
    CANCER SCIENCE, 2022, 113 : 1762 - 1762
  • [40] Synthesis of triterpenoid derivatives and their anti-tumor and anti-hepatic fibrosis activities
    Xu, Jing
    Wang, Xude
    Zhang, Hongyu
    Yue, Jiayin
    Sun, Yuanyuan
    Zhang, Xiaoshu
    Zhao, Yuqing
    NATURAL PRODUCT RESEARCH, 2020, 34 (06) : 766 - 772
12345